Cargando…
Molecular docking studies on DMDP derivatives as human DHFR inhibitors
Molecular docking is routinely used for understanding drug‐receptor interaction in modern drug design. Here, we describe the docking of 2, 4-diamino-5-methyl-5-deazapteridine (DMDP) derivatives as inhibitors to human dihydrofolate reductase (DHFR). We docked 78 DMDP derivates collected from literatu...
Autores principales: | Srivastava, Vivek, Kumar, Ashutosh, Mishra, Bhartendu Nath, Siddiqi, Mohammad Imran |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639668/ https://www.ncbi.nlm.nih.gov/pubmed/19238244 |
Ejemplares similares
-
CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents
por: Srivastava, Vivek, et al.
Publicado: (2008) -
Molecular docking studies on quinazoline antifolate derivatives as human thymidylate synthase inhibitors
por: Srivastava, Vivek, et al.
Publicado: (2010) -
Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR
por: David, Temitope.I, et al.
Publicado: (2018) -
Protein-Ligand interaction studies on 2, 4, 6- trisubstituted triazine derivatives as anti-malarial DHFR agents using AutoDock
por: Adinarayana, Katika Prabhakara Surya, et al.
Publicado: (2011) -
Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives
por: Bhargava, Kiran, et al.
Publicado: (2014)